science wire

« BACK

Health



Results 151 - 200 of 24940.


Health - Environment - 05.10.2021

Research Management - Health - 05.10.2021

Health - Life Sciences - 05.10.2021
$6.2 million NIH grant to support UCLA study of how COVID-19 causes multiple organ failure
Researchers from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received a $6.2 million grant from the National Institutes of Health to study how the SARS-CoV-2 virus causes damage throughout the body.

Health - Life Sciences - 05.10.2021

Computer Science - Health - 05.10.2021
New app to motivate aphasia recovery
A smartphone app to track and improve communication recovery for stroke survivors with aphasia is under development by University of Queensland researchers. UQ School of Health and Rehabilitation Sciences speech pathologist Dr Sarah Wallace said a co-design process with stroke survivors, their families and speech pathologists would be used to ensure the app was effective and practical.

Health - Campus - 05.10.2021
COVID-19: Coughing without masks, distancing alone is not enough
To prevent the spread of COVID-19 indoors, the two metres physical distancing guideline is not enough without masks, according to researchers from Quebec, Illinois, and Texas.

Health - Life Sciences - 05.10.2021
Sleep disorder linked to neurodegeneration is focus of $35 million USD grant
International team seeks hidden signs of brain damage in REM behavior disorder People with rapid eye movement (REM) sleep behavior disorder act out their dreams.

Health - Campus - 05.10.2021
COVID-19: Without masks, two metres distancing is not enough
To prevent the spread of COVID-19 indoors, the two metres physical distancing guideline is not enough without masks, according to researchers from Quebec, Illinois, and Texas.

Health - Life Sciences - 05.10.2021
A high-risk, high-reward approach to ALS
Multidisciplinary group of U-M researchers will investigate environmental exposures, chosen as one of the first projects in a new NIH amyotrophic lateral sclerosis initiative.

Health - Pharmacology - 05.10.2021
Black COVID patients: Less medical follow-up, longer return-to-work delays, more hospital readmissions
Black COVID patients: Less medical follow-up, longer return-to-work delays, more hospital readmissions
African American COVID-19 patients had the least physician follow-up and the longest delays in returning to work, a University of Michigan study found.

Health - Life Sciences - 05.10.2021
UW joins USAID's $125M project to detect emerging viruses with pandemic potential
UW joins USAID’s $125M project to detect emerging viruses with pandemic potential
To better identify and prevent future pandemics, the University of Washington has become a partner in a five-year global, collaborative agreement with the U.S. Agency for International Development.

Health - Law - 04.10.2021
Has COVID 19 undermined the rule of law? New research examines actions in the Western Balkans
The coronavirus pandemic has presented populist governments with a unique opportunity to implement authoritarian measures and to limit public scrutiny of their decisions and policies, argues Dr Andi

Health - Life Sciences - 04.10.2021
Wearable brain scanner to facilitate testing for children with epilepsy
A wearable brain scanner, co-developed by UCL researchers, is now being used in a specialist clinic for children with epilepsy.

Health - Life Sciences - 04.10.2021
Cancer in children with Fanconi anaemia and ataxia telangiectatica
Cancer in children with Fanconi anaemia and ataxia telangiectatica
Nationwide study with data from 50 years determines cancer risk of affected children Fanconi anaemia (FA) and ataxia teleangiectatica (AT) belong to the so-called cancer predisposition syndromes.

Health - Campus - 01.10.2021

Pharmacology - Health - 01.10.2021
Individualised immunosuppression improves prognosis for liver transplant patients
Individualised immunosuppression improves prognosis for liver transplant patients
Regular biopsies lead to less immunosuppression and fewer side effects Stand: 01.10.2021 After a liver transplant, patients have to take immune-suppressing drugs for the rest of their lives.

Health - Politics - 01.10.2021
Republican-led states lifted pandemic restrictions earlier
Republican-led states lifted pandemic restrictions earlier
In the firstámontháof theáCOVID-19ápandemic, nearly all 50ástates announcedárestrictions on gatherings andábusinesses, and most issued stay-at-home orders, aiming toácurbádisease transmission andáavoidáoverburdening health systems. Statesáeasedáthoseápoliciesábased on politics as much asáCOVID-19ádeath ratesáorácase counts, according to new research from the University of Washington.áThe researchers also foundáthat states with large Black communities,ádespite those communities beingáhit hardest by the pandemic, also lifted restrictions earlier.

Pharmacology - Health - 01.10.2021
Black patients’ Lyme disease often diagnosed late, possibly due to missed signs
FINDINGS A UCLA study suggests that many physicians may not have the knowledge or training to properly recognize how Lyme disease appears on the skin of Black patients.

Health - Life Sciences - 01.10.2021
For unvaccinated, reinfection by SARS-CoV-2 is likely
For unvaccinated, reinfection by SARS-CoV-2 is likely
Throughout the COVID-19 pandemic, there has been much uncertainty about how long immunity lasts after an unvaccinated person is infected with SARS-CoV-2.

Pharmacology - Health - 30.09.2021
Novartis data show rapid and effective disease activity control with remibrutinib (LOU064) in patients with chronic spontaneous urticaria
Results from a Phase IIb study show all remibrutinib doses provided significant improvements in UAS7 change from baseline at week 4 and week 12 compared to placebo, and a favorable safety profile acr

Health - Life Sciences - 30.09.2021

Social Sciences - Health - 30.09.2021
Rate of mental disorders among children remained stable in 2021 after previous rise | University of Cambridge
Rate of mental disorders among children remained stable in 2021 after previous rise | University of Cambridge
One in six children in England had a probable mental disorder in 2021 - a similar rate to 2020 but an increase from one in nine in 2017 - according to a survey published today by NHS Digital.

Health - Pharmacology - 30.09.2021
Oxford announces expansion of graduate access programme
Oxford announces expansion of graduate access programme
For the second year in a row, The British Medical Journal have selected a publication co-authored by Oxford researchers for their prestigious UK Research Paper of the Year Award.

Health - Pharmacology - 30.09.2021
Looking Beyond DNA to See Cancer with New Clarity
Mapping how mutated proteins interact reveals previously unknown drug targets Researchers at University of California San Diego and University of California San Francisco have mapped out how hundreds

Health - Sport - 30.09.2021
New Scoliosis Procedure Helps One-Time Olympic Hopeful Compete Again
In 1980, Michele Pease-Downey's dream was to qualify for the U.S. Olympic swimming team.

Health - Pharmacology - 30.09.2021
New state-of-the-art centre for immune disease opens
New state-of-the-art centre for immune disease opens
UCL scientists investigating the immune system will work alongside doctors, nurses and patients from the Royal Free Hospital, in a unique partnership that will enable new treatments to be developed more quickly for global health problems, including Covid-19, diabetes and cancer.

Economics / Business - Health - 30.09.2021

Life Sciences - Health - 29.09.2021
Unknown Childhood Genetic Condition and its Potential Cure
Findings point to the possibility of treating and preventing birth defects before birth Describing a previously unknown genetic condition that affects children, researchers at University of Californi

Computer Science - Health - 29.09.2021
Wyss Center announces CE mark for its brain data visualization software, Epios Cloud
The cloud-based platform enables long-term brain monitoring towards personalized treatment Geneva, Switzerland - The Wyss Center announced today the CE (ConformitÚ EuropÚenne) mark Class I medical device for its Epios Cloud software.

Pharmacology - Health - 29.09.2021
Novartis data show achieving complete control of chronic spontaneous urticaria (CSU) improves overall quality of life, as reported by patients
Data analysis shows that preventing the symptoms of CSU (achieving complete control) improves overall health-related quality of life (HRQoL); including sleep and work productivity, among other measur

Pharmacology - Health - 29.09.2021
New data reinforce efficacy and convenience of Novartis Cosentyx (secukinumab) 300 mg autoinjector in adults with psoriasis
New findings show Cosentyx (secukinumab) 300 mg single dose autoinjector (the UnoReady pen) resulted in superior efficacy vs placebo 1 Patient satisfaction with 300 mg autoinjector was high - reachin

Pharmacology - Health - 29.09.2021
Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria
Novartis and Medicines for Malaria Venture (MMV) report positive Phase 2b study results for novel non-artemisinin combination to treat uncomplicated malaria In the Phase 2b study conducted in childre

Pharmacology - Health - 29.09.2021
Opinion: Long-term antidepressant use is effective, but many people can come off them safely
Many people on depressants continue taking them for fear of having a relapse but new research could help doctors and patients make more informed decisions, say Dr Gemma Lewis and Professor Glyn Lewis (both UCL Psychiatry). The number of prescriptions written for antidepressants in wealthy countries hasádoubled in the past 20 years.

Health - Social Sciences - 29.09.2021
Prevention and early intervention critical to ending the cycle of family mental illness
An international group of researchers led by Monash University have developed a series of principles and recommendations to assist children whose parents are living with a mental illness.

Health - Life Sciences - 28.09.2021
In conversation with Silvia Scarabelli, PhD, Regulatory and Clinical Affairs Engineer
The 'in conversation' series features members of the Wyss Center community discussing their work, their collaborations and imagining the future.

Health - Pharmacology - 28.09.2021
Moonshot initiative to develop affordable COVID-19 antivirals gets funding boost
The COVID Moonshot, a non-profit, open-science consortium of scientists from around the world dedicated to the discovery of globally affordable and easily-manufactured antiviral drugs against COVID-1

Life Sciences - Health - 28.09.2021
New mouse model for studying the cognitive protection mechanisms in Alzheimer's
New mouse model for studying the cognitive protection mechanisms in Alzheimer’s
Alzheimer's is a neurodegenerative disease that features the accumulation of the beta-amyloid peptide and Tau protein in the brain, which are associated with deficits in the neuronal connections and with dementia. However, researchers have recently discovered a type of people that despite the accumulation of these molecules, they do not develop dementia: the NDAN patients (non-Demented with Alzheimer's disease Neuropathology).